Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2002-08-29
2010-11-30
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S053000, C514S061000, C536S017400
Reexamination Certificate
active
07842677
ABSTRACT:
Novel synthetic gangliosides and pharmaceutical compositions containing such synthetic gangliosides are described. Methods of making the novel synthetic ganglioside compounds and compositions as well as their use in the field of neuroprotection and cancer treatment is also described.
REFERENCES:
patent: 3954881 (1976-05-01), Bowler
patent: 4940694 (1990-07-01), della Valle et al.
patent: 5264424 (1993-11-01), Della Valle et al.
patent: 7273852 (2007-09-01), Tsuji et al.
patent: 2005/0032742 (2005-02-01), DeFrees et al.
patent: 2005/0245735 (2005-11-01), DeFrees
patent: 197 09 787 (1998-09-01), None
patent: 0 119 539 (1984-09-01), None
patent: 09 208461 (1997-08-01), None
patent: WO 98/40390 (1998-09-01), None
patent: WO 99/28491 (1999-06-01), None
Helling et al , Cancer Research, 1994, 54, 197-203.
Jennemann, Richard et al., “Specific Immunization Using Keyhole Umpet Hemocyanin-Ganglioside Conjugates”;Journal of Biochemistry, 1994, vol. 115, No. 6, pp. 1047-1052.
Helling, Friedhelm et al., “GD3Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines”;Cancer Research1994 vol. 54, pp. 197-203.
Ito, Yukishige et al., “A Novel Strategy for Synthesis of Ganglioside GM# Using an Enzymatically Produced Sialoside Glycosyl Donor”;Journal of the American Chemical Society1983, vol. 115 No. 4, pp. 1603-1605.
Bertozzi, C.R., et al., “Carbon-Linked Galactosphingolipid Analogs Bind specifically to HIV-1 gp120,”J. Am. Cchem. Soc., 1992, vol. 114, No. 26, pp. 10639-10641.
Binder, W.H., et al., “Galactosylation by Use of B-Galactosidase Chemo-Enzymatic Syntheses of Di and Trisaccharides,”Tetrahedron, 1994, vol. 50, No. 35, pp. 10407-10418.
De Rosa, S., et al., “Aliphatic and Aromatic Glycosides from the Cell Cultures of Lycopersicon Esculentum,”Phytochemistry, 1998, vol. 42, No. 4, pp. 1031-1034.
Guivisdalsky, P.N., et al., Synthesis and Antineoplastic Properties of Ether-Linked Thioglycolipids,J. Med. Chem., 1990, vol. 33, No. 9, pp. 2614-2621.
Koike, K., et al., “Total Synthesis of Cerebroside: (2S, 3R, 4E)-1-0-B-D-Galactopyranosyl-N(2′R and 2′S)-2′-Hydroxytetracosanoylsphingenine,”Carbohydrate Research, 1987, vol. 162, pp. 237-246.
Marinier A., et al., “Sulfated Galactocerebrosides as Potential Antiinflammatory Agents,”J. Med. Chem., 1997, vol. 40, No. 20, pp. 3234-3247.
Pf{hacek over (a)}ffli, P.J., et al., “Thioglycosides Having 0-Benzyl Blocking Groups as Intermediates for the Systematic, Sequential Synthesis of Oligosaccharides. Synthesis of isomaltose,”Carbohydrate Research, 1972, vol. 23, pp. 195-206.
Sogin, David C., et al. “Binding of Cytochalasin B to human Erythrocyte Glucose Transporter,”Biochemistry, 1980, vol. 19, No. 23, pp. 5417-5420.
Tsujihara, K., “A new class of Nitroureas. II synthesis and Antitumor Activity of 1-(2Chloroethyl)-3,3,Disubstituted-1nitrsoureas having a Glucopyranosyl, Mannopyranosyl or Galactopyranosyl Moiety,”Chem. Pharm. Bull., 1981, vol. 29, No. 11, pp. 3262-3273.
Yoshikawa, K., et al., “Aroma Glycosides from Hovenia Dulsis,”Phytochemistry, 1993, vol. 34 No. 5, pp. 1431-1433.
DeFrees Shawn
Wang Zhi Guang
Jiang Shaojia Anna
Krishnan Ganapathy
Morgan & Lewis & Bockius, LLP
Seneb Biosciences, Inc.
LandOfFree
Synthetic ganglioside derivatives and compositions thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic ganglioside derivatives and compositions thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic ganglioside derivatives and compositions thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4166921